STAT
MARCH 27, 2024
For years, researchers have been hopeful they could get under the hood of multiple sclerosis. The neurological condition shows up in over 2.5 million people around the world, but it doesn’t always look the same. If science could point its light in just the right way, patients might be sorted into disease subgroups, and treated more successfully depending on their kind of MS.
PharmaVoice
MARCH 27, 2024
Ahead of more guidance from the FDA on diversity in clinical trials, Takeda is aiming to beat industry standards.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
STAT
MARCH 27, 2024
Right now, inside your digestive tract, there are trillions of bacteria, fungi, and viruses that form a tiny universe known as the gut microbiome. New research shows that certain bacteria can alter antibodies so much that they’re unrecognizable to the body’s defenses — potentially leading to immune friendly fire. The bacteria, called Akkermansia muciniphila, can strip the sugar coating from IgA antibodies, immune proteins abundant in the gut.
pharmaphorum
MARCH 27, 2024
Incorporating the patient experience into observational studies can enhance the quality of real-world evidence gathered. Learn how patient-centred approaches can lead to stronger research outcomes.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
STAT
MARCH 27, 2024
WASHINGTON — Food corporations, grocery stores, and even tech companies are claiming they are a part of the growing effort to use food to treat medical conditions. Now, the nonprofits that pioneered the work want to standardize it. The Food is Medicine Coalition, an association of community-based nonprofit food providers, released a 32-page accreditation standard, which was shared first with STAT Wednesday.
pharmaphorum
MARCH 27, 2024
Brainomix's e-Lung AI can accurately identify idiopathic pulmonary fibrosis patients most likely to progress and could inform the clinical trial design for new therapies
Pharmacist Digest brings together the best content for pharmacists from the widest variety of industry thought leaders.
pharmaphorum
MARCH 27, 2024
Astellas has become the first drugmaker to bring a claudin 18.2 (CLDN18.2) targeted therapy to regulatory approval, getting a green light in Japan for Vyloy as a treatment for stomach cancer. The Ministry of Health, Labour and Welfare (MHLW) has cleared Vyloy (zolbetuximab) for use in combination with chemotherapy for patients with HER2-negative CLDN18.2-positive advanced or recurrent gastric cancer that cannot be treated with surgery.
STAT
MARCH 27, 2024
New biotech newsletter launching tomorrow. Don’t miss out. Good morning, everyone. Damian here with the details on a potentially major drug approval, an idea to make CAR-T more equitable, and the slow launch of a gene therapy.
Express Pharma
MARCH 27, 2024
Veeda Clinical Research has acquired Heads, a privately held European CRO, which specialises in conducting clinical trials in oncology. Established in 2010, Heads has operational presence in 25 multiple strategically important locations across Europe, North America and Asia Pacific region. Veeda expands its reach to major geographies and adds capabilities of late-sta. ge clinical trial execution with strong focus on oncology with this acqusition The acquisition provides Heads a strong operationa
STAT
MARCH 27, 2024
AstraZeneca filed a lawsuit seeking to block an Arkansas law that requires the company to ship its medicines to any pharmacy working with hospitals participating in a controversial federal discount program. The move comes less than a month after a U.S. appeals court upheld the same law, but the company is trying to make a different argument in hopes of stopping other states from pursuing similar laws.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
pharmaphorum
MARCH 27, 2024
More than half (52%) of people who participated in a major survey of the GB public were dissatisfied with the NHS, as staff shortages, strikes, and record waiting lists take their toll. The results from the annual British Social Attitudes (BSA) survey came from 3,000 people interviewed across England, Scotland, and Wales and showed that less than a quarter (24%) were satisfied with the health service, a 29 percentage drop in three years.
STAT
MARCH 27, 2024
Hello, everyone, and welcome to the middle of the week. Congratulations on making it this far, because it is an accomplishment, after all. The next step, of course, is to forge ahead. And why not? Just consider the alternatives. On that optimistic note, please join us for a needed cup or three of stimulation. Our choice today is caramel crème brulée.
pharmaphorum
MARCH 27, 2024
Brandon Newman, CEO of healthcare analytics firm Xevant, joins host Jonah Comstock on today’s episode of the pharmaphorum podcast.
Pharmaceutical Commerce
MARCH 27, 2024
In this Pharmaceutical Commerce video interview, Barry Heavey, Life Sciences Supply Chain Lead, Accenture, discusses how companies can leverage digital tools like artificial intelligence and machine learning to optimize manufacturing processes and ensure efficient production.
The Pharmacist
MARCH 27, 2024
Government and NHS officials have refuted a suggestion that the lines between pharmacists and pharmacy technicians are being 'blurred'. Speaking at the Health and Social Care (HSCC)’s pharmacy inquiry this week, Birmingham (Erdington) MP Paulette Hamilton said she was ‘concerned’ about the way pharmacy technicians were being represented to the public, and claimed some were […] The post No 'blurred lines' between pharmacy professionals, officials tell inquiry appeared first on The
pharmaphorum
MARCH 27, 2024
Get live coverage of the latest updates and developments from Day 2 of Reuters Pharma USA 2024. Stay informed with real-time news and insights from the event.
Pharmacy Joe
MARCH 27, 2024
In this episode, I’ll discuss the consolidated CHEST guidelines on antithrombotic therapy for venous thromboembolism disease. Episode 908: Finally, All the VTE Recommendations In One Document! Subscribe on iTunes , Android , or Stitcher The CHEST guidelines on venous thromboembolism disease are an invaluable resource, but one flaw that has persisted since 2016 has made referencing the guidelines awkward and inconvenient.
Outsourcing Pharma
MARCH 27, 2024
From math hater to a leader in clinical data, itâs been a long journey for Jennifer Visser-Rogers, vice president for statistical research and consultancy at Phastar.
Pharmaceutical Commerce
MARCH 27, 2024
A study investigates how a New Mexico law can impact patients’ out-of-pocket costs surrounding mental health and substance use disorder medications.
pharmaphorum
MARCH 27, 2024
Teva UK has joined forces with techbio company Closed Loop Medicine to develop digital companions for pharma products that could provide personalised medicine
Pharma Times
MARCH 27, 2024
PhaSER will provide 8HUM mouse models for the TDI to accelerate a pipeline of novel therapeutic targets
Outsourcing Pharma
MARCH 27, 2024
OSP senior editor, Liza Laws, took some time at SCOPE 2024 in Orlando earlier in the year to speak with two female-focused members of the Clinical Trials Media (CTM) team, Katherine Seay and Veronica Berk to find out how.
Pharma Times
MARCH 27, 2024
The progressive and incurable brain disorder currently affects approximately 100 patients worldwide
European Pharmaceutical Review
MARCH 27, 2024
According to SwedenBIO, Sweden‘s life sciences industry is witnessing a continued increase in export values. Based on statistics from Statistics Sweden, at SEK 152.5 billion, exports of pharmaceuticals reached a total of 7.3 percent of Sweden’s total export value. SwedenBIO highlighted that this is an almost 10 percent increase since 2022. Value of Swedish pharmaceutical exports Swedish pharmaceuticals exports are currently “significantly larger” than exports of iron and steel.
Welltopia Pharmacy
MARCH 27, 2024
Omega-3s and Stress Reduction: Unveiling the Calming Power of WellPure Omega 1300 EC Omega-3s and Stress Reduction In the whirlwind
European Pharmaceutical Review
MARCH 27, 2024
The US Food and Drug Administration (FDA) has approved WINREVAIR ( sotatercept -csrk) for subcutaneous injection (45mg, 60mg) for adults with pulmonary arterial hypertension (PAH, World Health Organization [WHO] Group 1). According to Merck (MSD outside of the US and Canada), WINREVAIR is the first activin signalling inhibitor therapy authorised for PAH.
BioPharma Dive
MARCH 27, 2024
The failure of a medicine known as TUDCA is yet another disappointment for ALS patients, as it comes just after Amylyx’s therapy Relyvrio proved unsuccessful in confirmatory testing.
European Pharmaceutical Review
MARCH 27, 2024
A report by Allied Market Research has predicted that the global pyrogen testing market will value $3.3 billion by 2032. The market is predicted to grow at a CAGR of 8.2 percent from 2023 to 2032, according to the research. Drivers of the pyrogen testing market Increased R&D activities within the pharmaceutical and biopharmaceutical sector and a focus on biologics, were reported to hold significant growth opportunities for the pyrogen testing market.
BioPharma Dive
MARCH 27, 2024
An arm of the private equity firm pledged up to $750 million in funding for Moderna’s flu shot development, in exchange for milestones and royalties.
Outsourcing Pharma
MARCH 27, 2024
In an exciting collaboration, modern mental health company, Clerkenwell Health, and Beckley Psytech, a clinical-stage biotechnology company, have launched a phase 2a study aimed at investigating a potential breakthrough treatment for alcohol use disorder (AUD).
BioPharma Dive
MARCH 27, 2024
The startup’s performance will test investors’ appetite for early-stage drugmakers, as Boundless has only advanced as far as Phase 1 clinical trials.
Pharmafile
MARCH 27, 2024
Heidelberg Pharma has announced that it has gained Orphan Drug Designation (ODD) from the US Food and Drug Administration (FDA) for HDP-101 for the treatment of multiple myeloma. The candidate is currently being investigated in a phase 1/2a clinical trial for the treatment of relapsed and refractory multiple myeloma (RRMM). HDP-101 is an antibody-drug conjugate […] The post Heidelberg Pharma gains FDA ODD for ATAC candidate appeared first on Pharmafile.
Pharmaceutical Business Review
MARCH 27, 2024
This collaboration is expected to leverage Cipla’s extensive distribution network to enhance the reach of Sanofi India’s CNS products. Under the agreement, Cipla will handle the distribution and promotion of six CNS brands owned by Sanofi India, including the anti-epileptic medication Frisium. Sanofi India retains ownership and will continue to import and manufacture products under its CNS range across plants in India and globally.
Pharmafile
MARCH 27, 2024
Merck, known as MSD outside of the US and Canada, has announced that the US Food and Drug Administration (FDA) has approved Winrevair (sotatercept-csrk) for the treatment of adult patients with pulmonary arterial hypertension (PAH). The drug is intended to increase exercise capacity, improve World Health Organization (WHO) functional class (FC) and reduce risk of […] The post FDA approves Merck’s Winrevair for PAH treatment appeared first on Pharmafile.
Drug Patent Watch
MARCH 27, 2024
Annual Drug Patent Expirations for ADVIL+DUAL+ACTION+WITH+ACETAMINOPHEN Advil Dual Action With Acetaminophen is a drug marketed by Haleon Us Holdings and is included in one NDA.
Expert insights. Personalized for you.
352 
Let's personalize your content